ArticleOncotarget2017

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.

Francesca Morgese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.